Founded in 1941 and headquartered in Tokyo, Eisai is a global, research-driven pharmaceutical company with over 80 years of innovation. Guided by its human health care (hhc) philosophy—giving first thought to patients and their families—Eisai Canada was established in 2011 to address critical treatment gaps across the country.
With a strategic focus in Neurology and Oncology, Eisai’s global team of approximately 10,000 employees works across R&D, manufacturing, and commercial operations to deliver breakthrough therapies.
The company’s commitment to open collaboration and cutting-edge science has led to an industry-leading pipeline targeting conditions such as cancer, epilepsy, insomnia, and Alzheimer’s disease. Eisai continues to invest in solutions that matter, improving lives through meaningful innovation.